Experience

• • Cerberus Capital Management in its acquisition of Cyanco International, the largest global producer of sodium cyanide.
  • Clayton, Dubilier & Rice in its acquisition of SunSource, a distributor of hydraulic and pneumatic fluid power products in the U.S. and Canada.
  • Clayton, Dubilier & Rice in its $500 million preferred stock investment in Beacon Roofing Supply’s $2.625 billion acquisition of Allied Building Products.
  • FS Investments in the formation of FS Investments Tactical Opportunities Fund, a private fund intended for institutional investors.
  • Gramercy in raising multiple emerging markets credit and distressed debt funds, including in the formation of:
  • Gramercy Capital Solutions Fund, a $312 million fund.
  • Gramercy Capital Solutions Fund II, a $592 million fund.
  • Gramercy Capital Solutions Fund III, a $685 million fund.
  • HarbourVest Partners in raising multiple funds and separate accounts, including in the formation of:
  • HarbourVest 2017 Global Fund, a $354 million global fund of funds.
  • Morgan Stanley Capital Partners in its sale of World 50 and its related subsidiary companies to a single asset GP-led continuation fund investment vehicle managed by an affiliate of MSCP.
  • Morgan Stanley Capital Partners in the sale of 24 Seven, a leading provider of digital marketing and creative staffing solutions, to a single asset GP-led continuation fund vehicle managed by an affiliate of MSCP.
  • Morgan Stanley Capital Partners and Morgan Stanley Credit Partners in various fund formation matters, including in the formation of:
  • North Haven Capital Partners VII, a $2 billion global buyout fund.
  • North Haven Credit Partners III, a $1.6 billion credit opportunities fund.
  • Providence Equity Partners in the formation of various funds and separate accounts specializing in media, entertainment, communications and information companies, including in the formation of:
  • Providence Equity Partners VIII, a $6 billion global media, entertainment and communications fund.
  • PSG IV, a $2 billion North America growth fund.
  • Sawai Pharmaceutical in the sale of a minority stake of its U.S. subsidiary, Upsher-Smith Laboratories, to Japanese trading house Sumitomo.
  • Sawai Pharmaceutical in its $1.05 billion acquisition of the generic pharmaceuticals business of Upsher-Smith Laboratories.
  • Tribune Media Company in its $6.6 billion sale, later terminated, to Sinclair Broadcast Group.